Icosapent Ethyl Capsules and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Icosapent Ethyl Capsules and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: icosapent
Brand name: Vascepa
Synonyms: Icosapent, Icosapent Ethyl
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Icosapent Ethyl Capsules-Insulin degludec
- Icosapent Ethyl Capsules-Insulin Degludec (U-100) Prefilled Pens
- Icosapent Ethyl Capsules-Insulin Degludec (U-100) Vials
- Icosapent Ethyl Capsules-Insulin Degludec (U-200) Prefilled Pens
- Icosapent Ethyl Capsules-Insulin degludec and liraglutide
- Icosapent Ethyl Capsules-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Icy Hot
- Insulin aspart, recombinant Subcutaneous-Icy Hot Arthritis Therapy Topical
- Insulin aspart, recombinant Subcutaneous-Icy Hot Lidocaine Plus Menthol
- Insulin aspart, recombinant Subcutaneous-Icy Hot PM
- Insulin aspart, recombinant Subcutaneous-Icy Hot PM (Capsaicin and Menthol Patch)
- Insulin aspart, recombinant Subcutaneous-Icy Hot with Capsaicin